Teva Pharmaceutical (TEVA) Amends Credit Facility, Extends Maturity to 2028
Teva Pharmaceutical (TEVA) amended its revolving credit agreement, extending the maturity date to April 29, 2028, and adjusting financial covenants.
Episode
00:00:00
00:00:00